Are angiotensin-converting enzyme inhibitors/angiotensin receptor blockers associated with reduced severe acute respiratory syndrome coronavirus 2 infections and improved outcomes, and does race matter?

Diabetes Obes Metab. 2022 Dec;24(12):2465-2468. doi: 10.1111/dom.14835. Epub 2022 Sep 8.
No abstract available

Keywords: ACE inhibitor; SARS-CoV-2; angiotensin receptor blocker.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiotensin Receptor Antagonists / therapeutic use
  • Angiotensin-Converting Enzyme Inhibitors* / therapeutic use
  • COVID-19 Drug Treatment*
  • Humans
  • Renin-Angiotensin System
  • SARS-CoV-2

Substances

  • Angiotensin-Converting Enzyme Inhibitors
  • Angiotensin Receptor Antagonists